Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment

Arthritis Care and Research

Volumn 63, Issue 10, 2011, Pages 1407-1414

  Van Hulst, L T C ^a   Kievit, W ^a   Van Bommel, R ^a   Van Riel, P L C M ^a   Fraenkel, L ^b,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; ARTHRALGIA; BONE EROSION; CLINICAL ASSESSMENT; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; FEMALE; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MOTIVATION; PATIENT CARE; PATIENT SATISFACTION; PRACTICE GUIDELINE; RATING SCALE; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATTITUDE OF HEALTH PERSONNEL; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT SELECTION; PATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 81255165968     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20551     Document Type: Review

References (32)

1. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
2. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, Ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA). Ann Rheum Dis 2007;66:1443-9.
3. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet 2004;364:263-9.
4. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, Vos K, van Schaardenburg D, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis 2010;69:65-9.
5. Fransen J, Moens HB, Speyer I, van Riel PL. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005;64:1294-8.
6. Fransen J, Stucki G, Twisk J, Chamot AM, Gerster JC, Langenegger T, et al. Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial. Ann Rheum Dis 2003;62:624-9.
7. Schipper LG, van Hulst LT, Grol R, van Riel PL, Hulscher ME, Fransen J. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Rheumatology (Oxford) 2010;49:2154-64.
8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46:328-46.
9. Kennedy T, McCabe C, Struthers G, Sinclair H, Chakravaty K, Bax D, et al. BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology (Oxford) 2005;44: 553-6.
10. Richtlijn. Dutch guideline for rheumatoid arthritis-diagnostics and treatment. 2007. URL: http://www.cbo.nl/Downloads507/rl-ra-09.pdf. In Dutch.
11. Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW. Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann Rheum Dis 2007;66 Suppl:iii56-60.
12. Kiely PD, Brown AK, Edwards CJ, O'Reilly DT, Ostor AJ, Quinn M, et al. Contemporary treatment principles for early rheumatoid arthritis: a consensus statement. Rheumatology (Oxford) 2009;48:765-72.
13. Van Hulst LT, Creemers MC, Fransen J, Li LC, Grol R, Hulscher ME, et al. How to improve DAS28 use in daily clinical practice? A pilot study of a nurse-led intervention. Rheumatology (Oxford) 2010;49:741-8.
14. Fraenkel L, Bogardus ST, Concato J, Felson DT, Wittink DR. Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis 2004;63:1372-8.
15. Kievit W, van Hulst L, Van Riel P, Fraenkel L. Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis. Arthritis Care Res (Hoboken) 2010;62:842-7.
16. Wolfe F, Michaud K. Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices. Arthritis Rheum 2007; 56:2135-42.
17. Jobanputra P, Wilson J, Douglas K, Burls A. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology (Oxford) 2004;43:206-10.
18. Chilton F, Collett RA. Treatment choices, preferences and decision-making by patients with rheumatoid arthritis. Musculoskeletal Care 2008;6:1-14.
19. Ahlmen M, Nordenskiold U, Archenholtz B, Thyberg I, Ronnqvist R, Linden L, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology (Oxford) 2005;44:105-10.
20. Benhamou M, Rincheval N, Roy C, Foltz V, Rozenberg S, Sibilia J, et al. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort. J Rheumatol 2009;36:934-42.
21. Fraenkel L, Rabidou N, Dhar R. Are rheumatologists' treatment decisions influenced by patients' age? Rheumatology (Oxford) 2006;45:1555-7.
22. Van Hulst LT, Kievit W, den Broeder AA, van Riel PL, Grol R, Fraenkel L, et al. Besides disease activity there are many other considerations made in the decision to intensify disease modifying treatment or not: a qualitative study. 2009. URL:http://acr.confex.com/acr/2009/webprogram/Paper13573.html.
23. Dutch Arthritis Association. Reumafonds. 2010. URL: www.reumafonds.nl.
24. Van Hulst L, Hulscher M, Grol R, van Riel P, Fransen J. Assessing the quality of RA management: understanding variation in daily clinical practice [abstract]. Ann Rheum Dis 2009;68 Suppl:403.
25. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282: 1458-65.
26. Sawtooth Software. Technical paper series: the MaxDiff/web v6.0 technical paper. 2007. URL: http://www.sawtoothsoftware.com/download/techpap/maxdifftech. pdf.
27. Flynn TN, Louviere JJ, Peters TJ, Coast J. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ 2007;26:171-89.
28. Orme B. Sawtooth Software. Technical paper series. Hierarchical Bayes: why all the attention? 2000. URL: http://www.sawtoothsoftware.com/download/ techpap/hbwhy.pdf.
29. Johnson RM. Sawtooth Software. Technical paper series. Understanding HB: an intuitive approach. 2000. URL: http://www.sawtoothsoftware.com/download/ techpap/undhb.pdf.
30. Martin RW, Head AJ, Rene J, Swartz TJ, Fiechtner JJ, McIntosh BA, et al. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician. J Rheumatol 2008;35:618-24.
31. Coast J, Salisbury C, de Berker D, Noble A, Horrocks S, Peters TJ, et al. Preferences for aspects of a dermatology consultation. Br J Dermatol 2006;155:387-92.
32. Legare F, Ratte S, Stacey D, Kryworuchko J, Gravel K, Graham ID, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev 2010;5:CD006732.